Apligraf pressure sore trials imminent:
This article was originally published in Clinica
Executive Summary
Organogenesis is to begin clinical trials in the new year of its Apligraf manufactured skin product to treat pressure sores. The FDA is considering the use of Apligraf, formerly known as Graftskin, in venous ulcers. US studies with diabetic ulcers are underway (see Clinica No 776, p 17). Apligraf is marketed in Canada for venous ulcers by Novartis Pharmaceuticals.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.